[Insights on glycated albumin]

Area of Science:

• Biochemistry
• Clinical Chemistry
• Endocrinology

Background:

• Plasma albumin is susceptible to glycation, forming glycated albumin.
• Glycation alters albumin's structure and function.
• Albumin glycation is more prevalent than hemoglobin glycation due to accessibility, concentration, and half-life.

Purpose of the Study:

• To highlight the significance of glycated albumin measurement.
• To present glycated albumin as a valuable biomarker for glycemic control.
• To explore its utility in specific clinical scenarios and patient populations.

Main Methods:

• Laboratory measurement of glycated albumin.
• Analysis of glycated albumin's correlation with glycemic balance.
• Evaluation of its prognostic value in chronic kidney disease.

Main Results:

• Glycated albumin reflects glycemic control over a 3-week period.
• Its measurement is advantageous when HbA1c determination is impossible or unreliable.
• Glycated albumin shows prognostic relevance in chronic kidney disease patients, both dialyzed and non-dialyzed.

Conclusions:

• Glycated albumin serves as a valuable biomarker for short-term glycemic control.
• It offers supplementary information to HbA1c and may replace fructosamine assays in certain cases.
• Glycated albumin has significant prognostic implications, particularly in chronic kidney disease management.